Accuracy Coverage Pricing Contact
GlaxoSmithKline

GlaxoSmithKline (GSK)

GlaxoSmithKline is a very large UK based pharmaceutical company with an excellent track record of delivering increased dividends to shareholders. In recent years it has been changing its strategy and reducing it's dependence on the pure pharmaceuticals business.

Fundamentals

Optimized Dividends

Annual Dividends

Year Amount Change
2006 48.0p
2007 53.0p 10.4%
2008 57.0p 7.5%
2009 61.0p 7.0%
2010 65.0p 6.6%
2011 70.0p 7.7%
2012 74.0p 5.7%
2013 78.0p 5.4%
2014 80.0p 2.6%
2015 80.0p 0%
2016 80.0p 0%
2017 80.0p 0%
2018 Login required
2019 Login required
2020 Login required

Dividends

Ex-Div Date Pay Date Year Type Frequency Status Amount
05 May 2010 08 Jul 2010 2010 Interim Quarterly Paid 15p
28 Jul 2010 07 Oct 2010 2010 Interim Quarterly Paid 15p
27 Oct 2010 06 Jan 2011 2010 Interim Quarterly Paid 16p
09 Feb 2011 07 Apr 2011 2010 Final Quarterly Paid 19p
04 May 2011 07 Jul 2011 2011 Interim Quarterly Paid 16p
03 Aug 2011 06 Oct 2011 2011 Interim Quarterly Paid 16p
02 Nov 2011 05 Jan 2012 2011 Interim Quarterly Paid 17p
15 Feb 2012 12 Apr 2012 2011 Final Quarterly Paid 21p
09 May 2012 05 Jul 2012 2012 Interim Quarterly Paid 17p
08 Aug 2012 04 Oct 2012 2012 Interim Quarterly Paid 17p
14 Nov 2012 03 Jan 2013 2012 Interim Quarterly Paid 18p
20 Feb 2013 11 Apr 2013 2012 Final Quarterly Paid 22p
08 May 2013 11 Jul 2013 2013 Interim Quarterly Paid 18p
07 Aug 2013 03 Oct 2013 2013 Interim Quarterly Paid 18p
13 Nov 2013 09 Jan 2014 2013 Interim Quarterly Paid 19p
19 Feb 2014 10 Apr 2014 2013 Final Quarterly Paid 23p
14 May 2014 10 Jul 2014 2014 Interim Quarterly Paid 19p
06 Aug 2014 02 Oct 2014 2014 Interim Quarterly Paid 19p
06 Nov 2014 08 Jan 2015 2014 Interim Quarterly Paid 19p
19 Feb 2015 09 Apr 2015 2014 Final Quarterly Paid 23p
14 May 2015 09 Jul 2015 2015 Interim Quarterly Paid 19p
13 Aug 2015 01 Oct 2015 2015 Interim Quarterly Paid 19p
12 Nov 2015 14 Jan 2016 2015 Interim Quarterly Paid 19p
18 Feb 2016 14 Apr 2016 2015 Final Quarterly Paid 23p
18 Feb 2016 14 Apr 2016 2015 Special Irregularly Paid 20p
12 May 2016 14 Jul 2016 2016 Interim Quarterly Paid 19p
11 Aug 2016 13 Oct 2016 2016 Interim Quarterly Paid 19p
03 Nov 2016 12 Jan 2017 2016 Interim Quarterly Paid 19p
23 Feb 2017 13 Apr 2017 2016 Final Quarterly Paid 23p
11 May 2017 13 Jul 2017 2017 Interim Quarterly Paid 19p
10 Aug 2017 12 Oct 2017 2017 Interim Quarterly Paid 19p
09 Nov 2017 11 Jan 2018 2017 Interim Quarterly Paid 19p
22 Feb 2018 12 Apr 2018 2017 Final Quarterly Paid 23p
10 May 2018 12 Jul 2018 2018 Interim Quarterly Paid 19p
09 Aug 2018 11 Oct 2018 2018 Interim Quarterly Paid 19p
15 Nov 2018 10 Jan 2019 2018 Interim Quarterly Declared 19p
Login Login 2018 Final Quarterly Forecast Login
Login Login 2019 Interim Quarterly Forecast Login
Login Login 2019 Interim Quarterly Forecast Login
Login Login 2019 Interim Quarterly Forecast Login
Login Login 2019 Final Quarterly Forecast Login
Login Login 2020 Interim Quarterly Forecast Login
Login Login 2020 Interim Quarterly Forecast Login
Login Login 2020 Interim Quarterly Forecast Login
Login Login 2020 Final Quarterly Forecast Login
Login Login 2021 Interim Quarterly Forecast Login

Recent news articles

Investment Tools Limited

Summary

Read more
Investment Tools Limited

Summary

Read more
Investment Tools Limited

We start 2015 focused on priorities critical to GSK's performance this year. These include completion of the proposed major 3-part transaction with Novartis, improved commercialisation of new products and progression of our mid-stage R&D pipeline, capitalising on product supply resumption in our Consumer business and execution of our pharmaceutical restructuring programme.

Read more
Investment Tools Limited

First quarter dividend +6% to 19p. Share buy backs of £1-2 billion targeted during 2014

Read more
Investment Tools Limited

Summary

Read more
Investment Tools Limited

GSK announces Q2 core EPS growth of 4% and dividend of 18p

Read more
Investment Tools Limited
Investment Tools Limited

GSK delivers2012 core EPS of 112.7p and returns £6.3 billion to shareholders

Read more
Investment Tools Limited

Ok. It is big Pharma time. I am going to use the DividendMax tool to select on sector and then use other criteria to try and whittle down to the best Pharma dividend stock out there and that will become my dividend of the week.

Read more
Investment Tools Limited

This article which appeared in the Saturday edition of the FT on 27th October talks about investors chasing dividends. It is a good read and vindicates our stance that the only reason to invest in equities at the present time is for Dividends.

Read more

GlaxoSmithKline optimized dividend - 12 month history

Optimized dividend graph demo

GlaxoSmithKline share price - 12 month history

You're currently viewing outdated and/or artificial data.

Try the real thing now:

Activate Free Trial